Literature DB >> 3756840

Role of high-, low- and very low-density lipoproteins in the transport and tumor-delivery of hematoporphyrin in vivo.

A Barel, G Jori, A Perin, P Romandini, A Pagnan, S Biffanti.   

Abstract

Free hematoporphyrin administered intravenously to healthy rabbits (1-28 mg/kg body weight) is bound by the 3 major lipoprotein components of plasma (VLDL, LDL and HDL) with different efficiency. In vitro-prepared complexes of hematoporphyrin (Hp) with lipoprotein fractions isolated from mouse serum have been injected intracardiacally into mice affected by MS-2 fibrosarcoma (1 mg of Hp per kg body weight). LDL appear to allow a more specific delivery of the complexed Hp to the tumor tissue as compared with HDL, VLDL or free Hp. The different behavior of VLDL, LDL and HDL as carriers of Hp in vivo is also discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3756840     DOI: 10.1016/0304-3835(86)90112-6

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  12 in total

Review 1.  Nanoparticle systems for cancer vaccine.

Authors:  Ru Wen; Afoma C Umeano; Yi Kou; Jian Xu; Ammad Ahmad Farooqi
Journal:  Nanomedicine (Lond)       Date:  2019-02-26       Impact factor: 5.307

2.  pH effect on cellular uptake of Sn(IV) chlorine e6 dichloride trisodium salt by cancer cells in vitro.

Authors:  Khaled A Al-Khaza'leh; Khalid Omar; M S Jaafar
Journal:  J Biol Phys       Date:  2010-10-30       Impact factor: 1.365

3.  Mechanisms in photodynamic therapy: Part three-Photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction.

Authors:  Ana P Castano; Tatiana N Demidova; Michael R Hamblin
Journal:  Photodiagnosis Photodyn Ther       Date:  2005-08-10       Impact factor: 3.631

4.  Liver cancer targeting of Doxorubicin with reduced distribution to the heart using hematoporphyrin-modified albumin nanoparticles in rats.

Authors:  Ji-Eun Chang; Won-Sik Shim; Su-Geun Yang; Eun-Young Kwak; Saeho Chong; Dae-Duk Kim; Suk-Jae Chung; Chang-Koo Shim
Journal:  Pharm Res       Date:  2011-10-05       Impact factor: 4.200

5.  Higher irradiance and photodynamic therapy for age-related macular degeneration (an AOS thesis).

Authors:  Joan W Miller
Journal:  Trans Am Ophthalmol Soc       Date:  2008

6.  A practical test for in vitro evaluation of photosensitization: assessment with hematoporphyrin derivative (HPD).

Authors:  A Croisy; D Carrez; D Zilberfarb
Journal:  Cytotechnology       Date:  1990-03       Impact factor: 2.058

7.  The distribution of porphyrins with different tumour localising ability among human plasma proteins.

Authors:  M Kongshaug; J Moan; S B Brown
Journal:  Br J Cancer       Date:  1989-02       Impact factor: 7.640

8.  Size-dependent resistance of human tumour spheroids to photodynamic treatment.

Authors:  C M West
Journal:  Br J Cancer       Date:  1989-04       Impact factor: 7.640

9.  Liposome-delivered Si(IV)-naphthalocyanine as a photodynamic sensitiser for experimental tumours: pharmacokinetic and phototherapeutic studies.

Authors:  V Cuomo; G Jori; B Rihter; M E Kenney; M A Rodgers
Journal:  Br J Cancer       Date:  1990-12       Impact factor: 7.640

10.  Evidence for low-density lipoprotein receptor-mediated uptake of benzoporphyrin derivative.

Authors:  B A Allison; P H Pritchard; J G Levy
Journal:  Br J Cancer       Date:  1994-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.